5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 57.41▼ | 57.31▼ | 57.30▼ | 57.99▼ | 58.31▼ |
MA10 | 57.39▼ | 57.34▼ | 57.59▼ | 57.91▼ | 60.30▼ |
MA20 | 57.32▼ | 57.59▼ | 57.87▼ | 58.44▼ | 64.87▼ |
MA50 | 57.32▼ | 57.90▼ | 57.98▼ | 60.87▼ | 73.04▼ |
MA100 | 57.57▼ | 57.96▼ | 57.74▼ | 65.88▼ | 73.63▼ |
MA200 | 57.82▼ | 57.76▼ | 59.30▼ | 73.17▼ | 74.13▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.006▲ | -0.021▼ | -0.079▼ | 0.163▲ | -0.519▼ |
RSI | 42.480▼ | 39.250▼ | 40.590▼ | 39.732▼ | 25.358▼ |
STOCH | 70.383 | 29.279 | 30.453 | 57.817 | 14.157▼ |
WILL %R | -83.607▼ | -76.628▼ | -79.667▼ | -61.496 | -91.909▼ |
CCI | -77.316 | -48.340 | -88.404 | -60.055 | -107.266▼ |
Friday, May 02, 2025 05:40 AM
Hologic (HOLX) stock plunges as the company's Q2 FY25 results show a revenue decline and a lowered earnings forecast. Read more here.
|
Friday, May 02, 2025 12:15 AM
Despite a slight revenue decline, Hologic Inc (HOLX) demonstrates resilience with strong diagnostics growth and strategic financial positioning.
|
Thursday, May 01, 2025 02:50 PM
Medical technology company Hologic (NASDAQ:HOLX) in Q1 CY2025, but sales fell by 1.2% year on year to $1.01 billion. On the other hand, next quarter’s revenue guidance of $1.01 billion was less ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 57.54 | 57.93 | 56.955 | 57.28 | 2,512,222 |
30/04/25 | 58.57 | 58.57 | 57.56 | 58.20 | 2,877,893 |
29/04/25 | 57.70 | 58.58 | 57.655 | 58.35 | 1,211,270 |
28/04/25 | 58.39 | 58.49 | 57.68 | 58.08 | 1,579,271 |
25/04/25 | 58.30 | 58.34 | 57.28 | 58.02 | 1,814,362 |
24/04/25 | 58.47 | 58.605 | 57.745 | 58.29 | 2,254,509 |
23/04/25 | 58.99 | 59.50 | 57.86 | 58.15 | 2,387,437 |
22/04/25 | 57.34 | 58.28 | 57.305 | 58.19 | 1,849,991 |
21/04/25 | 57.46 | 57.46 | 56.39 | 56.94 | 2,068,316 |
17/04/25 | 56.27 | 57.75 | 55.89 | 57.56 | 6,818,925 |
|
|
||||
|
|
||||
|
|